What GLP-1 medications does Medicare cover?
Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Medicare currently covers GLP-1 medications only when prescribed for FDA-approved indications other than weight loss. Ozempic, Mounjaro, and Trulicity are covered for type 2 diabetes when medically indicated. Wegovy and Zepbound — both FDA-approved specifically for chronic weight management — are not covered by Medicare. The Treat and Reduce Obesity Act has been introduced in Congress to change this, but as of 2026 it has not become law. Medicare Advantage plans sometimes offer expanded coverage; check your specific plan documents. Medicaid coverage varies significantly by state.
Where to start
Licensed US telehealth services that handle this. We may earn a commission when you sign up. See disclosure.
Ro
from $145/mo- Best for insured patients
- Best for clinical oversight
Ro Body — branded GLP-1 weight care program
Hims
from $199/mo- Best for cash-pay
- Best for speed
Hims Weight Loss — compounded GLP-1 from $199/mo
Noom Med
from $179/mo- Best for coaching
- Best for maintenance
Noom Med — GLP-1 + behavioral psychology coaching
Drugs referenced
Related questions
Does insurance cover Wegovy?
Wegovy coverage depends on three things: your insurance plan's formulary, your BMI and comorbidities, and whether your plan covers weight-loss drugs at all. Many commercial plans require BMI ≥30 (or ≥27 with a weight-related comorbidity like hypertension or sleep apnea) and prior authorization. Medicare does not currently cover anti-obesity medications inclu